School of Public Policy and Management, Guangxi University, Nanning, China.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2225991. doi: 10.1080/21645515.2023.2225991. Epub 2023 Jun 20.
COVID-19 vaccination is a fundamental step toward controlling the COVID-19 pandemic and defusing the public health crisis it has caused. Existing studies have demonstrated that equitable distribution of COVID-19 vaccines can only be achieved if these vaccines are treated as public goods. The question remains how to transform COVID-19 vaccines into public goods. In this paper, based on the theory of commons governance, the theoretical mechanism is analyzed to realize the adequate distribution of COVID-19 vaccines. Furthermore, feasible methods on how COVID-19 vaccines can benefit the people through the successful popularization of these vaccines in China are summarized. The results show that to ensure adequate supply of COVID-19 vaccines, government intervention is required because the government can expand the supply of the vaccine by balancing individual benefits for producing enterprises and the overall benefits for society. The government can also guarantee the right of every member in society to receive COVID-19 vaccines, thus enabling these vaccines to benefit the whole nation. By analyzing how COVID-19 vaccines benefit the people, this paper further verifies that national intervention plays an essential role in the supply and distribution of COVID-19 vaccines in both developed and developing countries. It may further mean that state intervention can play an essential role in continuing to respond to major public health events in the possible future.
新冠病毒疫苗接种是控制新冠疫情和化解其造成的公共卫生危机的基本步骤。现有研究表明,只有将新冠病毒疫苗视为公共产品,才能实现公平分配。问题在于如何将新冠病毒疫苗变为公共产品。本文基于公地治理理论,分析了实现新冠病毒疫苗充分分配的理论机制,并总结了中国通过成功推广新冠病毒疫苗使疫苗惠及民众的可行方法。结果表明,为确保新冠病毒疫苗的充足供应,需要政府干预,因为政府可以通过平衡生产企业的个体利益和社会的整体利益来扩大疫苗供应。政府还可以保证社会每个成员接种新冠病毒疫苗的权利,使这些疫苗惠及全民。通过分析新冠病毒疫苗如何使民众受益,本文进一步验证了国家干预在发达国家和发展中国家新冠病毒疫苗供应和分配中的重要作用。这可能意味着,国家干预在应对未来可能出现的重大公共卫生事件方面可以发挥重要作用。